As high expression of LDHA and/or LDHB is associated with poor prognosis, these enzymes, as well as MCT1 and MCT4 lactate transporters, can serve as important therapeutic targets for anti-cancer therapy. The gene discussed is SLC16A1; the disease is cancer.